Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

SR One Capital Management

Status
ACTIVE
Global HQ
Seattle, United States
Countries of investment
  • Israel
  • USA
  • Canada
  • India
Investment stages
  • Seed
Industries
  • Health Tech
  • PropTech
About
SR One is a biotech venture capital firm translating innovative science into medicines, focusing on strong fundamentals and novel approaches to disease treatment.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

SR One takes a backandbuild approach to its investments, focusing on companies with strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a robust background in private equity, the fund manager has successfully executed over 30 deals across the technology and healthcare sectors. Active primarily in North America and Europe, their strategic approach emphasizes an operator-first style, leveraging operational expertise to drive value creation. Notable exits include several high-growth companies that have significantly outperformed market expectations, underscoring a data-driven investment thesis. Their experience spans various stages of investment, from growth capital to late-stage buyouts, showcasing a versatility that enhances portfolio resilience.

SR One Capital Management Contacts Information

Primary contact

Secondary contact

Team

Vikas Goyal

Simeon George

Rajeev Dadoo

Rajeev Dadoo

Philip Smith

Michael Diem

Karen Engel

Jill Carroll

James Macadam

Deborah Harland

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp